Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Abbott Laboratories (NY: ABT)
36.21 USD  -1.30 (-3.47%)
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Abbott Laboratories
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Abbott Laboratories (ABT) Crosses Pivot Point Support at $37.03
Today 10:18 EDT
from Comtex SmarTrend® News Briefs
Wednesday’s Small Cap Biotech Catalyst Watch And Trade List
Today 8:30 EDT
category Pharmaceuticals
from Trefis
Noteworthy ETF Inflows: VIG, ABT, MCD, OXY
June 18, 2013
Symbols mentioned in this story: VIG, ABT, MCD, OXY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers... Read More
category NYSE:MRK , NYSE:PFE , NYSE:BMY , and 1 more.
from Forbes Real Time
Truth Behind 1Q 2013 Earnings and What’s Next for Stocks
June 18, 2013
category Pharmaceuticals , Industrials , Internet
from Trefis
Pacts that delay sale of generics in jeopardy
June 18, 2013
A Surpreme Court decision Monday could lead to more challenges of deals that drug makers strike to stave off the arrival of inexpensive generic competition. Read More
category ABBV , Market News , General , and 6 more.
from MarketWatch
This Week’s Seminal Event
June 17, 2013
category Market/Outlook , Week/Ahead , Market/Outlook/2013/Q2 , and 1 more.
from Wall Street Greek
10 Food Stocks With Tasty Potential
June 14, 2013
As their incomes rise, Chinese demand safer (and better) foods, providing a huge opening for international companies to expand their share of a quickly growing market. Read More
category ABT , MKC
from Minyanville Headlines
Daily Dividend Report: ABT, LHO, DX, AT, RLJ
June 14, 2013
This afternoon, Abbott Laboratories (ABT) declared its quarterly dividend of 14 cents per share, maintaining the amount paid to shareholders the last quarter. With the dividend announcement, the... Read More
category Dividends
from Dividend Channel
Boston Scientific: Upside Scenario To Our Estimates
June 14, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
Abbott Laboratories (ABT) Declares $0.14 Quarterly Dividend; 1.5% Yield
June 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8418034 for the full story. Read More
from StreetInsider.com News Articles
Abbott (ABT) Approves New $3B Buyback Plan
June 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8418029 for the full story. Read More
from StreetInsider.com News Articles
Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend
June 14, 2013
from PR Newswire
As top court invalidates some gene patents, biotech has moved on
June 13, 2013
NEW YORK, June 13 (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely... Read More
category companyNews
from Reuters: Company News
Despite Billions Of Dollars Saved, Congress Tries To Thwart Medicare's Competitive Bidding
June 13, 2013
The wagons are circling from Congress on the Obama Administration’s effort to rein in massive amounts of unnecessary spending by Medicare on unnecessary medical equipment from wheelchairs and walkers... Read More
category NYSE:JNJ , NYSE:ABT , NASDAQ:AMZN
from Forbes Real Time
Abbott Begins Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold
June 11, 2013
Abbott (NYSE: ABT ) today announced that it has initiated the ABSORB Japan randomized controlled clinical trial to evaluate the Absorb™ Bioresorbable Vascular Scaffold (BVS) in patients with coronary... Read More
category Benzinga , News , ABT
from Latest Articles from Benzinga.com
Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold
June 11, 2013
- Trial to Study the Innovative "Dissolving" Heart Device Compared to Abbott's Market-Leading Drug Eluting Stents in Patients with Coronary Artery Disease in Japan Read More
from PR Newswire
While The Dollar Rises, Multinationals Dive
June 11, 2013
 Read More
category NYSE:HOG , NYSE:DE , Stock Picks , and 3 more.
from InvestorPlace - Latest Headlines
Abbott to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference
June 10, 2013
from PR Newswire
Jefferies Lowers Price Target on Abbott Laboratories; Remains Top US Pharma Pick (ABT)
June 10, 2013
On Friday, analysts at Jefferies reiterated their view that Abbott Laboratories (ABT) is the best US pharmaceutical stock, but lowered its price target. The analysts rate ABT as “Buy,” but now see... Read More
category abt , Dividend Stocks , abbott laboratories
from Dividend Daily
RBCC Explores New Funding for Expansion
June 10, 2013
from Business Wire News Releases
UPDATE: Jefferies Lowers PT on Abbott Laboratories as Top US Pharma Pick
June 07, 2013
In a report published Friday, Jefferies analyst Jeffrey Holford reiterated a Buy rating on Abbott Laboratories (NYSE: ABT ), but lowered the price target from $46.00 to $44.00. In the report, Jefferies... Read More
category Benzinga , Jeffrey Holford , Price Target , and 4 more.
from Latest Articles from Benzinga.com
Before the Bell Scans of BSX, ABT, ZMH, and ETRM
June 07, 2013
from ACCESSWIRE
How to Play the Invest-for-Tomorrow Game in Medtech: Alan Brochstein
June 06, 2013
Source: George S. Mack of The Life Sciences Report (6/6/13) http://www.thelifesciencesreport.com/pub/na/15341 Alan Brochstein of AB Analytical Services blogs, publishes and creates model portfolios for... Read More
category BSX , MDT , MASI , and 9 more.
from Bio-Wire.Com
Jefferies Raises Price Target on Abbott Labs; Sees 26.7% Upside (ABT)
June 06, 2013
Following a number of restructuring moves, Jefferies analysts believe that pharmaceutical company Abbott Laboratories (ABT) is among the most attractive plays in its industry. As such, the analysts... Read More
category abt , Dividend Stocks , abbott laboratories
from Dividend Daily
RBCC Poised To Gain Share Of $142 Billion Market
June 05, 2013
from Business Wire News Releases
Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation
June 04, 2013
- Findings Published in the Journal of the American College of Cardiology Demonstrate Significant Improvements in Day-to-Day Quality of Life Read More
from PR Newswire
Abbott to Present at William Blair 33rd Annual Growth Stock Conference
June 04, 2013
from PR Newswire
Bio-Wire Equity Surveillance – Closing Bell 5/31/2013
May 31, 2013
Friday May 31st, 2013 Overview The market saw a nasty bearish reversal in the afternoon, which hit the healthcare sector just as badly as the rest of the market (if not a little worse in the high beta... Read More
category Bio/Wire
from Bio-Wire.Com
Abbott to Present at Goldman Sachs 34th Annual Global Healthcare Conference
May 31, 2013
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Boeing to Airbus: Game On
Nick Shchetko
2
The Future of Android Looks More Like Apple Inc.
Mike Schuster
3
Markets Take a Beating Post-Fed
Minyanville Staff
4
The Waning Integrity of US Financial Markets
Todd Harrison
5
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster